Dr. Dorcas Chi, MD

Dr. Chi practices at UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health.

Dr. Chi's NPI, 1922040609, was assigned on June 10, 2006. Dr. Chi graduated from Tufts University School Of Medicine in 2003. Dr. Chi holds California license C159144.

Dr. Chi's primary practice is UCLA Santa Monica Medical Center, at 1250 16th Street, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 319-4000.

Dr. Chi's primary practice is UCLA Santa Monica Medical Center in Santa Monica, California, part of University of California Health. Dr. Chi is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Chi to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chi practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Chi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Chi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Chi's licenses on file in 2 states: California and Massachusetts.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and neutropenia among the conditions Dr. Chi treats.

CMS data shows 12,111 Medicare services from Dr. Chi across 19 procedure codes in 2024, for 291 Medicare patients. Medicare paid $249,629 for them.

CMS counts 291 Medicare patients who saw Dr. Chi in 2024. The largest group is 65 to 74, with 160 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 29% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chi's median patient age at 61, with 78% women.

In 2024, Dr. Chi wrote 872 Medicare Part D claims for 164 patients. 81% of them were for generic drugs. CMS names the drug for 608 of them, across 18 drugs with 11 or more claims each, at $1,316,860 in total drug cost. In 2023, CMS named 597 claims across 16 drugs.

Dr. Chi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chi as offering telehealth.

Dmand AI links 4 papers to Dr. Chi, published from 2011 to 2013. 2011 was the busiest year, with 2. Dr. Chi's most frequent co-authors are Jeffrey William Clark, MD, Henning A. Gaissert, MD and Olga N. Kozyreva, MD.

Dmand AI links Dr. Chi to 6 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating and Breast Carcinoma In Situ. SWOG Cancer Research Network sponsors the most, 2.

CMS Open Payments shows 6 general payments to Dr. Chi from 5 drug and device companies from 2016 to 2025. Education make up the largest share, 68% of the total. Janssen Pharmaceuticals, Inc paid the most, $74.

Dr. Chi graduated from Tufts University School Of Medicine in 2003.

Dr. Chi is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.